|
🐜
|
Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study
26 auth.
M. Augustin,
P. Schommers,
M. Stecher,
F. Dewald,
L. Gieselmann,
H. Gruell,
C. Horn,
K. Vanshylla,
V. Cristanziano,
Luise Osebold,
Maria Roventa,
T. Riaz,
Nikolai Tschernoster,
J. Altmueller,
L. Rose,
...
S. Salomon,
Vanessa Priesner,
J. Luers,
C. Albus,
S. Rosenkranz,
B. Gathof,
G. Fätkenheuer,
M. Hallek,
F. Klein,
I. Suárez,
C. Lehmann
|
9 |
2021 |
9
🐜
|
|
🐜
|
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
24 auth.
F. Klein,
Ariel Halper-Stromberg,
J. Horwitz,
H. Gruell,
J. Scheid,
S. Bournazos,
H. Mouquet,
L. Spatz,
R. Diskin,
A. Abadir,
...
Trinity M Zang,
M. Dorner,
E. Billerbeck,
Rachael N. Labitt,
C. Gaebler,
Paola M. Marcovecchio,
R. Incesu,
Thomas R. Eisenreich,
P. Bieniasz,
M. Seaman,
P. Bjorkman,
J. Ravetch,
A. Ploss,
M. Nussenzweig
|
8 |
2012 |
8
🐜
|
|
🐜
|
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
37 auth.
M. Caskey,
T. Schoofs,
H. Gruell,
A. Settler,
T. Karagounis,
Edward F. Kreider,
B. Murrell,
N. Pfeifer,
Lilian Nogueira,
Thiago Y. Oliveira,
G. Learn,
Yehuda Z. Cohen,
C. Lehmann,
D. Gillor,
I. Shimeliovich,
...
Cecilia Unson-O’Brien,
D. Weiland,
Alexander Robles,
T. Kümmerle,
C. Wyen,
R. Levin,
M. Witmer-Pack,
Kemal Eren,
C. Ignacio,
S. Kiss,
A. West,
H. Mouquet,
B. Zingman,
R. Gulick,
T. Keler,
P. Bjorkman,
M. Seaman,
B. Hahn,
G. Fätkenheuer,
S. Schlesinger,
M. Nussenzweig,
F. Klein
|
8 |
2017 |
8
🐜
|
|
🐜
|
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
36 auth.
Pilar Mendoza,
H. Gruell,
Lilian Nogueira,
J. Pai,
Allison L. Butler,
Katrina G. Millard,
C. Lehmann,
I. Suárez,
Thiago Y. Oliveira,
J. C. Lorenzi,
Yehuda Z. Cohen,
C. Wyen,
T. Kümmerle,
T. Karagounis,
Ching-Lan Lu,
...
L. Handl,
Cecilia Unson-O’Brien,
R. Patel,
Carola Ruping,
M. Schlotz,
M. Witmer-Pack,
I. Shimeliovich,
G. Kremer,
E. Thomas,
K. Seaton,
Jill Horowitz,
A. West,
P. Bjorkman,
G. Tomaras,
R. Gulick,
N. Pfeifer,
G. Fätkenheuer,
M. Seaman,
F. Klein,
M. Caskey,
M. Nussenzweig
|
8 |
2018 |
8
🐜
|
|
🦁
|
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
9 auth.
H. Gruell,
K. Vanshylla,
P. Tober-Lau,
D. Hillus,
P. Schommers,
C. Lehmann,
...
F. Kurth,
L. Sander,
F. Klein
|
8 |
2021 |
8
🦁
|
|
🐜
|
SARS‐CoV‐2 targets neurons of 3D human brain organoids
23 auth.
Anand Ramani,
L. Müller,
P. Ostermann,
E. Gabriel,
Pranty Abida‐Islam,
A. Müller-Schiffmann,
Aruljothi Mariappan,
O. Goureau,
H. Gruell,
Andreas Walker,
...
M. Andrée,
S. Hauka,
Torsten Houwaart,
A. Dilthey,
K. Wohlgemuth,
H. Omran,
Florian Klein,
Dagmar Wieczorek,
Ortwin Adams,
Jörg Timm,
C. Korth,
H. Schaal,
Jay Gopalakrishnan
|
8 |
2020 |
8
🐜
|
|
🐜
|
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
27 auth.
C. Kreer,
Matthias Zehner,
Timm Weber,
Cornelius Rohde,
Sandro Halwe,
M. Ercanoglu,
L. Gieselmann,
M. Korenkov,
H. Gruell,
P. Schommers,
K. Vanshylla,
V. Di Cristanziano,
H. Janicki,
R. Brinker,
Artem Ashurov,
...
Verena Krähling,
A. Kupke,
H. Cohen-Dvashi,
M. Koch,
Simone Lederer,
N. Pfeifer,
T. Wolf,
M. Vehreschild,
C. Wendtner,
R. Diskin,
S. Becker,
F. Klein
|
8 |
2020 |
8
🐜
|
|
🐜
|
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
71 auth.
D. Hillus,
T. Schwarz,
P. Tober-Lau,
K. Vanshylla,
Hana Hastor,
C. Thibeault,
Stefanie Jentzsch,
E. Helbig,
L. Lippert,
Patricia Tscheak,
Marie L Schmidt,
Johanna Riege,
André Solarek,
C. von Kalle,
C. Dang‐Heine,
...
H. Gruell,
Piotr Kopankiewicz,
N. Suttorp,
C. Drosten,
H. Bias,
J. Seybold,
Ben Al-Rim,
Lara Bardtke,
J. Beheim-Schwarzbach,
Kerstin Behn,
L. Bergfeld,
N. Bethke,
T. Bleicker,
D. Briesemeister,
Sophia Brumhard,
C. Conrad,
S. Dieckmann,
Doris Frey,
Julie-Anne Gabelich,
Philipp Georg,
Ute Gläser,
Lisbeth Hasler,
Andreas Hetey,
A. Hiller,
A. Horn,
Claudia Hülso,
Luisa Kegel,
Willi M. Koch,
A. Krannich,
Paolo Kroneberg,
Michelle Lisy,
P. Mackeldanz,
Birgit Maeß,
Friederike Münn,
N. Olk,
C. Peiser,
Kai Pohl,
Annelie Hermel,
M. Rönnefarth,
Carolin Rubisch,
Angela Sanchez Rezza,
Isabelle Schellenberger,
Viktoria Schenkel,
Jenny Schlesinger,
S. Schmidt,
Georg Schwanitz,
Anne-Sophie Sinnigen,
Paula Stubbemann,
Julia Tesch,
D. Treue,
D. Wendisch,
S. Zvorc,
F. Klein,
F. Kurth,
V. Corman,
L. Sander
|
8 |
2021 |
8
🐜
|
|
🐜
|
Safety and anti-viral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
33 auth.
Y. Bar-On,
H. Gruell,
T. Schoofs,
J. Pai,
Lilian Nogueira,
Allison L. Butler,
Katrina G. Millard,
C. Lehmann,
I. Suárez,
Thiago Y. Oliveira,
T. Karagounis,
Yehuda Z. Cohen,
C. Wyen,
S. Scholten,
L. Handl,
...
Shiraz A. Belblidia,
Juan P Dizon,
J. Vehreschild,
M. Witmer-Pack,
I. Shimeliovich,
Kanika Jain,
Kerstin Fiddike,
K. Seaton,
N. Yates,
Jill Horowitz,
R. Gulick,
N. Pfeifer,
G. Tomaras,
M. Seaman,
G. Fätkenheuer,
M. Caskey,
F. Klein,
M. Nussenzweig
|
7 |
2018 |
7
🐜
|
|
🐜
|
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
24 auth.
F. Klein,
K. Vanshylla,
V. Cristanziano,
Franziska Kleipass,
F. Dewald,
P. Schommers,
L. Gieselmann,
H. Gruell,
M. Schlotz,
M. Ercanoglu,
...
Ricarda Stumpf,
P. Mayer,
E. Heger,
W. Johannis,
C. Horn,
I. Suárez,
N. Jung,
S. Salomon,
K. Eberhardt,
G. Fätkenheuer,
N. Pfeifer,
R. Eggeling,
M. Augustin,
C. Lehmann
|
7 |
2021 |
7
🐜
|
|
🐜
|
Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity
14 auth.
Julia Niessl,
A. Baxter,
Pilar Mendoza,
M. Jankovic,
Yehuda Z. Cohen,
Allison L. Butler,
Ching-Lan Lu,
M. Dubé,
I. Shimeliovich,
H. Gruell,
...
F. Klein,
M. Caskey,
M. Nussenzweig,
D. Kaufmann
|
6 |
2020 |
6
🐜
|
